{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2023,10,4]],"date-time":"2023-10-04T00:30:40Z","timestamp":1696379440466},"reference-count":59,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"1","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2013,1]]},"DOI":"10.1097\/mbc.0b013e32835a72aa","type":"journal-article","created":{"date-parts":[[2012,11,9]],"date-time":"2012-11-09T07:11:02Z","timestamp":1352445062000},"page":"59-63","source":"Crossref","is-referenced-by-count":3,"title":["Multiple markers of hypercoagulation in patients with history of venous thromboembolic disease"],"prefix":"10.1097","volume":"24","author":[{"given":"Murray","family":"Bern","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Nancy","family":"McCarthy","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"276","reference":[{"key":"R1-10-20210203","first-page":"S315","article-title":"Venous thromboembolic disease: which coagulation screening, for whom, when Rev Med B","volume":"26","author":"Wautrecht","year":"2005","journal-title":"rux"},{"key":"R2-10-20210203","doi-asserted-by":"crossref","first-page":"2472","DOI":"10.1001\/jama.2009.853","article-title":"Predictive value of factor V Leiden and prothrombin G20210A in adults with venous thromboembolism and in family members of those with a mutation: a systematic review.","volume":"301","author":"Segal","year":"2009","journal-title":"JAMA"},{"key":"R3-10-20210203","doi-asserted-by":"crossref","first-page":"729","DOI":"10.1001\/archinte.166.7.729","article-title":"Risk of recurrent venous thromboembolism in patients with common thrombophilia: a systematic review.","volume":"166","author":"Ho","year":"2006","journal-title":"Arch Intern Med"},{"key":"R4-10-20210203","doi-asserted-by":"crossref","first-page":"80","DOI":"10.1111\/j.1365-2141.2005.05715.x","article-title":"The Thrombosis: Risk and Economic Assessment of Thrombophilia Screening (TREATS) Study. Screening for thrombophilia in high-risk situations: a meta-analysis and cost- effectiveness analysis.","volume":"131","author":"Wu","year":"2005","journal-title":"Br J Haemtol"},{"key":"R5-10-20210203","doi-asserted-by":"crossref","first-page":"1","DOI":"10.3310\/hta10110","article-title":"Screening for thrombophilia in high-risk situations: systematic review and cost effectiveness analysis. The Thrombosis: Risk and Economic Assessment of Thrombophilia Screening (TREATS) study.","volume":"10","author":"Wu","year":"2006","journal-title":"Health Technol Assess"},{"key":"R6-10-20210203","doi-asserted-by":"crossref","first-page":"62","DOI":"10.1053\/j.seminhematol.2007.02.004","article-title":"Epidemiology and risk factors for venous thrombosis.","volume":"44","author":"Cushman","year":"2007","journal-title":"Semin Hematol"},{"key":"R7-10-20210203","doi-asserted-by":"crossref","first-page":"374","DOI":"10.3324\/haematol.10828","article-title":"Venous thromboembolism-a manifestation of the metabolic syndrome.","volume":"92","author":"Ay","year":"2007","journal-title":"Haematologica"},{"key":"R8-10-20210203","doi-asserted-by":"crossref","first-page":"382","DOI":"10.1055\/s-0037-1615216","article-title":"Hemostatic effects of oral contraceptives in women who developed deep-vein thrombosis while using oral contraceptives.","volume":"80","author":"Bloemenkamp","year":"1998","journal-title":"Thromb Haemost"},{"key":"R9-10-20210203","doi-asserted-by":"crossref","first-page":"511","DOI":"10.1097\/PCC.0b013e3181849dfe","article-title":"A retrospective study of the risk factors associated with hypercoagulability in the pediatric patients at a tertiary care childrens hospital.","volume":"9","author":"Slamon","year":"2008","journal-title":"Pediatr Crit Care Med"},{"key":"R10-10-20210203","doi-asserted-by":"crossref","first-page":"650","DOI":"10.1016\/j.atherosclerosis.2010.06.028","article-title":"Haemostatic alterations in overweight children: associations between metabolic syndrome, thrombin generation and fibrinogen levels.","volume":"212","author":"Fritch","year":"2010","journal-title":"Atherosclerosis"},{"key":"R11-10-20210203","doi-asserted-by":"crossref","first-page":"55","DOI":"10.1177\/1076029607304408","article-title":"Hemostasis activation in thrombophilic subjects with and without a history of venous thrombosis.","volume":"14","author":"Cuderman","year":"2008","journal-title":"Clin Appl Thromb Hemost"},{"key":"R12-10-20210203","doi-asserted-by":"crossref","first-page":"218","DOI":"10.7326\/0003-4819-152-4-201002160-00006","article-title":"for the POST (Prospective Observational Superficial Thrombophlebitis) Study GroupSuperficial venous thrombosis and venous thromboembolism. A large, prospective epidemiologic study.","volume":"152","author":"Decousus","year":"2010","journal-title":"Ann Intern Med"},{"key":"R13-10-20210203","doi-asserted-by":"crossref","first-page":"937","DOI":"10.1111\/j.1538-7836.2007.02507.x","article-title":"Frequency of renal impairment, advanced age, obesity and cancer in venous thromboembolism patients in clinical practice.","volume":"5","author":"Cook","year":"2007","journal-title":"J Thromb Haemost"},{"key":"R14-10-20210203","doi-asserted-by":"crossref","first-page":"413","DOI":"10.1097\/00042737-200204000-00014","article-title":"Persistent activation of coagulation and fibrinolysis after treatment of active ulcerative colitis.","volume":"14","author":"van Bodegraven","year":"2002","journal-title":"Eur J Gastroenterol Hepatol"},{"key":"R15-10-20210203","doi-asserted-by":"crossref","first-page":"273","DOI":"10.1159\/000187209","article-title":"Plasma parameters of the prothrombotic state in chronic uremia.","volume":"63","author":"Sagripanti","year":"1993","journal-title":"Nephron"},{"key":"R16-10-20210203","first-page":"16","article-title":"Superficial venous thrombosis of the lower limbs: prospective analysis in 100 patients.","volume":"26","author":"Gillet","year":"2001","journal-title":"J Mal Vasc"},{"key":"R17-10-20210203","first-page":"24","article-title":"Acquired and genetic risk factors for deep vein thrombosis of lower extremities among Lebanese.","volume":"60","author":"Kreidy","year":"2012","journal-title":"J Med Liban"},{"key":"R18-10-20210203","doi-asserted-by":"crossref","first-page":"895","DOI":"10.7326\/0003-4819-127-10-199711150-00007","article-title":"Factor V Leiden mutation and the risks of thromboembolic disease: a clinical perspective.","volume":"127","author":"Price","year":"1997","journal-title":"Ann Intern Med"},{"key":"R19-10-20210203","doi-asserted-by":"crossref","first-page":"566","DOI":"10.1161\/01.CIR.0000137123.55051.9B","article-title":"Risk factors and recurrence rate of primary deep vein thrombosis of the upper extremities.","volume":"110","author":"Martinelli","year":"2004","journal-title":"Circulation"},{"key":"R20-10-20210203","doi-asserted-by":"crossref","first-page":"858","DOI":"10.1182\/blood.V97.4.858","article-title":"; Childhood Thrombophilia Study Group. Risk of recurrent venous thrombosis in children with combined prothrombotic risk factors.","volume":"97","author":"Nowak-Gottl","year":"2001","journal-title":"Blood"},{"key":"R21-10-20210203","doi-asserted-by":"crossref","first-page":"47","DOI":"10.1007\/s12687-010-0011-3","article-title":"Hereditary thrombophilic risk factors for recurrent pregnancy loss.","volume":"1","author":"Bogdanova","year":"2010","journal-title":"J Community Genet"},{"key":"R22-10-20210203","first-page":"59","article-title":"Thrombophilia as a multigenic disease.","volume":"84","author":"Zoller","year":"1999","journal-title":"Haematologica"},{"key":"R23-10-20210203","first-page":"627","article-title":"Is thrombophilia a major risk factor for deep vein thrombosis of the lower extremities among Lebanese patients Vasc Health Risk M","volume":"5","author":"Kreidy","year":"2009","journal-title":"anag"},{"key":"R24-10-20210203","doi-asserted-by":"crossref","first-page":"66","DOI":"10.1055\/s-2005-863807","article-title":"Multilaboratory testing in thrombophilia through the United Kingdom National External Quality Assessment Scheme (Blood Coagulation) Quality Assurance Program.","volume":"31","author":"Jennings","year":"2005","journal-title":"Semin Thromb Hemost"},{"key":"R25-10-20210203","doi-asserted-by":"crossref","first-page":"802","DOI":"10.1055\/s-0037-1615068","article-title":"A common 4G allele in the promoter of the plasminogen activator inhibitor-1 (PAI-1) gene as a risk factor for pulmonary embolism and arterial thrombosis in hereditary protein S deficiency.","volume":"79","author":"Zoller","year":"1998","journal-title":"Thromb Haemostas"},{"key":"R26-10-20210203","doi-asserted-by":"crossref","first-page":"232","DOI":"10.1515\/CCLM.2007.038","article-title":"Plasma homocysteine cutoff values for venous thrombosis.","volume":"45","author":"Castanon","year":"2007","journal-title":"Clin Chem Lab Med"},{"key":"R27-10-20210203","first-page":"1095","article-title":"Screening for inherited thrombophilia: implications and therapeutic implications.","volume":"87","author":"De Stefano","year":"2002","journal-title":"Haematologica"},{"key":"R28-10-20210203","doi-asserted-by":"crossref","first-page":"120","DOI":"10.1309\/KV0632LJ8EDMEWQT","article-title":"An evaluation of thrombophilia screening in an urban Tertiary care medical center: a real world experience.","volume":"126","author":"Somma","year":"2006","journal-title":"Am J Clin Pathol"},{"key":"R29-10-20210203","first-page":"695","article-title":"The risk of recurrent venous thromboembolism in patients with inherited deficiency of natural anticoagulants antithrombin, protein C, and protein S.","volume":"91","author":"De Stefano","year":"2006","journal-title":"Haematologica"},{"key":"R30-10-20210203","doi-asserted-by":"crossref","first-page":"19","DOI":"10.1024\/0301-1526.37.1.19","article-title":"Evidence-based indications for thrombophilia screening.","volume":"37","author":"Lindhoff-Last","year":"2008","journal-title":"Vasa"},{"key":"R31-10-20210203","doi-asserted-by":"crossref","first-page":"457","DOI":"10.1160\/TH07-02-0138","article-title":"The risk of venous and arterial thrombosis in hyperhomocysteinemia is low and mainly depends on concomitant thrombophilic defects.","volume":"98","author":"Lijfering","year":"2007","journal-title":"Thromb Haemost"},{"key":"R32-10-20210203","doi-asserted-by":"crossref","first-page":"759","DOI":"10.1056\/NEJM199603213341203","article-title":"Hyperhomocysteinemia as a risk factor for deep-vein thrombosis.","volume":"334","author":"den Heijer","year":"1996","journal-title":"N Engl J Med"},{"key":"R33-10-20210203","doi-asserted-by":"crossref","first-page":"874","DOI":"10.1055\/s-0037-1615380","article-title":"Hyperhomocysteinemia and venous thrombosis: a meta-analysis.","volume":"80","author":"den Heijer","year":"1998","journal-title":"Thromb Haemost"},{"key":"R34-10-20210203","doi-asserted-by":"crossref","first-page":"1507","DOI":"10.1007\/s11999-008-0498-7","article-title":"Genetic polymorphisms in venous Thrombosis and pulmonary embolism after total hip arthroplasty: a pilot study.","volume":"467","author":"Ringwald","year":"2009","journal-title":"Clin Orthop Relat Res"},{"key":"R35-10-20210203","doi-asserted-by":"crossref","first-page":"168","DOI":"10.1177\/1076029607305620","article-title":"Hereditary thrombophilic risk factors and venous thromboembolism in Istanbul, Turkey: The role of different clinical manifestations of venous thromboembolism.","volume":"14","author":"Okumus","year":"2008","journal-title":"Clin Appl Thromb Hemost"},{"key":"R36-10-20210203","doi-asserted-by":"crossref","first-page":"71","DOI":"10.1097\/00001721-199801000-00009","article-title":"Increased risk of venous thrombosis in carriers of natural anticoagulant deficiencies. Results of the family studies of the Spanish Multicenter Study on Thrombophilia (EMET study).","volume":"9","author":"Mateo","year":"1998","journal-title":"Blood Coagul Fibrinolysis"},{"key":"R37-10-20210203","doi-asserted-by":"crossref","first-page":"673","DOI":"10.1093\/ajcp\/110.5.673","article-title":"The results of diagnostic studies for thrombophilia in a large group of patients with a personal or family history of thrombosis.","volume":"110","author":"Dumenco","year":"1998","journal-title":"Am J Clin Path"},{"key":"R38-10-20210203","first-page":"1","article-title":"Outcomes of genetic testing in adults with a history of venous thromboembolism.","volume":"180","author":"Segal","year":"2009","journal-title":"Evid Rep Technol Asses"},{"key":"R39-10-20210203","doi-asserted-by":"crossref","first-page":"1107","DOI":"10.3324\/haematol.10234","article-title":"The risk of recurrent venous thromboembolism among heterozygous carriers of factor V Leiden or prothrombin G20210A mutation. A systematic review of prospective studies.","volume":"92","author":"Marchiori","year":"2007","journal-title":"Haematologica"},{"key":"R40-10-20210203","doi-asserted-by":"crossref","first-page":"271","DOI":"10.1016\/S0049-3848(00)00324-8","article-title":"Mild hyperhomocysteinemia and fibrinolytic factors in patients with history of venous thromboembolism.","volume":"100","author":"Bozic","year":"2000","journal-title":"Thromb Res"},{"key":"R41-10-20210203","doi-asserted-by":"crossref","first-page":"1764","DOI":"10.1093\/clinchem\/39.9.1764","article-title":"Total homocysteine in plasma or serum: methods and clinical applications.","volume":"39","author":"Ueland","year":"1993","journal-title":"Clin Chem"},{"key":"R42-10-20210203","doi-asserted-by":"crossref","first-page":"793","DOI":"10.1111\/j.1538-7836.2006.01856.x","article-title":"Edith Collaborative Study GroupHyperhomocysteinemia and low B vitamin levels are independently associated with venous thromboembolism: results from the EDITH study: a hospital-based case-control study.","volume":"4","author":"Oger","year":"2006","journal-title":"J Thromb Haemost"},{"key":"R43-10-20210203","first-page":"566","article-title":"Hyperhomocysteinemia is a risk factor of recurrent venous thromboembolism.","volume":"80","author":"Eichinger","year":"1998","journal-title":"Thromb Haemost"},{"key":"R44-10-20210203","doi-asserted-by":"crossref","first-page":"342","DOI":"10.1159\/000083825","article-title":"Homocysteine, vitamin B6, and risk of recurrent venous thromboembolism.","volume":"33","author":"Eichinger","year":"20032004","journal-title":"Pathophysiol Haemost Thromb"},{"key":"R45-10-20210203","doi-asserted-by":"crossref","first-page":"61","DOI":"10.1016\/S1084-8592(97)80012-4","article-title":"Risk of venous thrombosis in carriers of a common mutation in the homocysteine regulatory enzyme methylenetetrahydrofolate reductace.","volume":"2","author":"Ocal","year":"1997","journal-title":"Mol Diag"},{"key":"R46-10-20210203","doi-asserted-by":"crossref","first-page":"797","DOI":"10.1093\/ajcp\/102.6.797","article-title":"An evaluation of 200 consecutive patients with spontaneous or recurrent thrombosis for primary hypercoagulation states.","volume":"102","author":"Doig","year":"1994","journal-title":"Am J Clin Pathol"},{"key":"R47-10-20210203","doi-asserted-by":"crossref","first-page":"574","DOI":"10.1177\/1076029610361334","article-title":"Failure to lyse venous thrombi because of elevated plasminogen activator inhibitor 1. (The PAI-14G Syndrome).","volume":"16","author":"Bern","year":"2010","journal-title":"Clin Appl ThrombHemo"},{"key":"R48-10-20210203","doi-asserted-by":"crossref","first-page":"890","DOI":"10.5858\/2007-131-890-HTIIS","article-title":"Hypercoagulation testing in ischemic stroke.","volume":"131","author":"Rahemtullah","year":"2007","journal-title":"Arch Pathol Lab Med"},{"key":"R49-10-20210203","first-page":"256","article-title":"Familial thrombophilia: a complex disorder.","volume":"34","author":"Koeleman","year":"1997","journal-title":"Semin Hematol"},{"key":"R50-10-20210203","doi-asserted-by":"crossref","first-page":"444","DOI":"10.1055\/s-0038-1655986","article-title":"Laboratory evaluation and clinical characteristics of 2,132 consecutive unselected patients with venous thromboembolism-Results of the Spanish Multicentric Study of Thrombophilia (EMET-Study).","volume":"77","author":"Mateo","year":"1997","journal-title":"Thromb Haemost"},{"key":"R51-10-20210203","doi-asserted-by":"crossref","first-page":"S3","DOI":"10.1016\/j.amjsurg.2009.10.006","article-title":"Risk assessment as a guide for the prevention of the many faces of venous thromboembolism.","volume":"199","author":"Caprini","year":"2010","journal-title":"Am J Surg"},{"key":"R52-10-20210203","doi-asserted-by":"crossref","first-page":"131","DOI":"10.1007\/s11999-010-1514-2","article-title":"Hematologic genetic testing in high risk patients before knee arthroplasty: a pilot study.","volume":"469","author":"Behair","year":"2011","journal-title":"Clin Orthop Relat Res"},{"key":"R53-10-20210203","first-page":"743","article-title":"Are patients with thrombophilia and previous venous thromboembolism at higher risk to arterial thrombosis Thromb R","volume":"121","author":"Linnemann","year":"2008","journal-title":"es"},{"key":"R54-10-20210203","first-page":"265","article-title":"Hemorheological alterations and hypercoagulable state in deep vein thrombosis.","volume":"19","author":"Mira","year":"1998","journal-title":"Clin Hemorheol Microcirc"},{"key":"R55-10-20210203","first-page":"24","article-title":"Characteristics of hemocoagulation in different periods of the development of a venous intravascular thrombus.","volume":"20","author":"Shumakov","year":"1975","journal-title":"Probl Gematol Pereliv Krovi"},{"key":"R56-10-20210203","doi-asserted-by":"crossref","first-page":"448","DOI":"10.1056\/NEJM199902113400607","article-title":"Acute-phase proteins and other systemic responses to inflammation.","volume":"340","author":"Gabay","year":"1999","journal-title":"N Engl J Med"},{"key":"R57-10-20210203","doi-asserted-by":"crossref","first-page":"1045","DOI":"10.1631\/jzus.2005.B1045","article-title":"Acute phase reaction and acute phase proteins.","volume":"6","author":"Gruys","year":"2005","journal-title":"J Zhejiang Univ Sci B"},{"key":"R58-10-20210203","doi-asserted-by":"crossref","first-page":"190","DOI":"10.1097\/MBC.0b013e328343f7be","article-title":"Postoperative changes in procoagulant factors after major surgery.","volume":"22","author":"Lison","year":"2011","journal-title":"Blood Coagul Fibrinolysis"},{"key":"R59-10-20210203","doi-asserted-by":"crossref","first-page":"334","DOI":"10.1093\/aje\/kwj051","article-title":"Hemostatic factors, inflammatory markers, and progressive peripheral atherosclerosis: the Edinburgh Artery Study.","volume":"163","author":"Tzoulaki","year":"2006","journal-title":"Am J Epidemiol"}],"container-title":["Blood Coagulation & Fibrinolysis"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/journals.lww.com\/10.1097\/MBC.0b013e32835a72aa","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,1,31]],"date-time":"2022-01-31T02:35:32Z","timestamp":1643596532000},"score":1,"resource":{"primary":{"URL":"https:\/\/journals.lww.com\/00001721-201301000-00010"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2013,1]]},"references-count":59,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2013]]}},"URL":"https:\/\/doi.org\/10.1097\/mbc.0b013e32835a72aa","relation":{},"ISSN":["0957-5235"],"issn-type":[{"value":"0957-5235","type":"print"}],"subject":[],"published":{"date-parts":[[2013,1]]}}}